ORX:STO
Orexo AB
SEK 1.37
arrow_downward
-1.58%(-0.022) 1D
Nov 6, 5:29:49 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 1.47
High
SEK 1.47
Low
SEK 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEK 36.00
52-wk low
SEK 1.30
EPS
SEK 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEK 1.47
High
SEK 1.47
Low
SEK 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEK 36.00
52-wk low
SEK 1.30
EPS
SEK 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
www.tmgm.com
·
13 hours ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
富途牛牛
·
2 hours ago
JPMorgan: The momentum crash is a mid-cycle correction within the AI supercycle; maintains S&P 500 target at 8,000 points.
BigGo Finance
·
12 hours ago
Dow Falls Another 237 Points; AI Stocks Rebound but Rate-Hike Expectations Weigh
Investing.com
·
13 hours ago
S&P cuts Uganda outlook to stable on oil delays and widening fiscal deficit
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com